Summary of Study ST000476
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000320. The data can be accessed directly via it's Project DOI: 10.21228/M8MP4W This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000476 |
Study Title | Metabolomic analysis of oxytocin effects on social deficits in mice (part IV) |
Study Summary | This metabolomics pilot study evaluated serum from mice treated with oxytocin and vehicle to understand how these factors influence the metabotype. |
Institute | University of North Carolina |
Laboratory | Sumner Lab |
Last Name | Sumner |
First Name | Susan |
Address | Eastern Regional Comprehensive Metabolomics Resource Core, UNC Nutrition Research Institute, 500 Laureate Way, Kannapolis, NC, 28081 |
susan_sumner @unc.edu | |
Phone | 704-250-5066 |
Submit Date | 2016-08-31 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2017-10-03 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000320 |
Project DOI: | doi: 10.21228/M8MP4W |
Project Title: | Metabolomic analysis of oxytocin effects on social deficits in mice |
Project Summary: | The goal of this study was to determine the effects of the neuropeptide oxytocin (OT) on metabolomic profiles, using a mouse model of autism-like behavior, the BALB/cByJ inbred strain. We have previously reported that subchronic treatment with OT can lead to persistent reversal of social deficits in BALB/cByJ and other models of autism spectrum disorder (ASD). In this study, mice were given a subchronic regimen with either vehicle or OT, and then evaluated for social approach. At the end of the study, brain and blood were collected for metabolomic analysis. In addition, fecal samples were taken at different time points during the treatment and testing regimen. The results from this project could elucidate mechanisms underlying the prosocial effects of oxytocin, and identify new targets for the development of highly specific oxytocin-related drugs. |
Institute: | University of North Carolina at Chapel Hill |
Department: | Department of Psychiatry |
Last Name: | Moy |
First Name: | Sheryl |
Address: | CB# 7146, Chapel Hill, NC 277599 |
Email: | ssmoy@med.unc.edu |
Phone: | 919-966-3082 |
Subject:
Subject ID: | SU000497 |
Subject Type: | Murine |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Species Group: | Mammal |
Factors:
Subject type: Murine; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA024348 | S_8 | Oxytocin |
SA024349 | S_3 | Oxytocin |
SA024350 | S_1 | Oxytocin |
SA024351 | S_19 | Oxytocin |
SA024352 | S_5 | Oxytocin |
SA024353 | S_17 | Oxytocin |
SA024354 | S_15 | Oxytocin |
SA024355 | S_6 | Oxytocin |
SA024356 | S_10 | Oxytocin |
SA024357 | S_14 | Oxytocin |
SA024358 | S_12 | Oxytocin |
SA024359 | S_2 | Oxytocin |
SA024360 | PS_1 | Pool |
SA024361 | PS_2 | Pool |
SA024362 | S_13 | Veh |
SA024363 | S_7 | Veh |
SA024364 | S_18 | Veh |
SA024365 | S_9 | Veh |
SA024366 | S_4 | Veh |
SA024367 | S_16 | Veh |
SA024368 | S_11 | Veh |
SA024369 | S_20 | Veh |
Showing results 1 to 22 of 22 |
Collection:
Collection ID: | CO000491 |
Collection Summary: | Trunk blood was collected into centrifuge tubes and centrifuged for 15 min at ~1,000 x g at 4o C. Supernatant (serum) was extracted, frozen on dry ice, and stored at -80o C. |
Sample Type: | Blood |
Treatment:
Treatment ID: | TR000511 |
Treatment Summary: | BALB/cByJ male mice (4-5 weeks in age; Jackson Laboratory, Bar Harbor, ME) were given four treatments of either vehicle or OT (1.0 mg/kg; IP) across 8 days, with at least 48 hours between each injection. Mice were evaluated in a 3-chamber choice test for social preference 24 hr after the final injection. |
Sample Preparation:
Sampleprep ID: | SP000504 |
Sampleprep Summary: | 30 µL of each serum sample was transferred to a new, pre-labeled 1.5 mL LoBind eppendorf tube to make the individual study samples, and 12 µL was transferred to a new, pre-labeled 1.5 mL LoBind Eppendorf to make the total pool. The total pool was aliquoted into 3 Total Pool QC Samples and 4 Column Equilibrium samples with volumes of 30 µL in 1.5 mL LoBind Eppendorf tubes. 600 uL of Lipid Extraction Solvent (PC(17:0/17:0) 50 µg/mL in 2:1 dichloromethane:methanol) was added to all samples, and samples were vortexed at 4,000 rpm for 2mins on multiple-tube vortexer. 120 µL of H2O was added to each tube and the samples were vortexed at 4,000 rpm for 1min. Samples sat at room temperature for 10 minutes, and were centrifuged at 16,000 rcf for 10 min at 10°C. 240 µL of the lower lipid-rich DCM layer was transferred into new pre-labeled 1.5 mL LoBind Eppendorf tubes, and rubber stoppers were inserted. Samples were placed at -80˚C for 60 mins, and then lyophilized for 19.5 hrs. 240 µL of ACN/IPA/H2O (65:30:5 v/v/v) was added to each sample, and the samples were vortexed at 4,000 rpm for 2mins and centrifuged at 16,000 rcf for 4 min. 225 µL of the supernatant was transferred to pre-labeled autosampler vials and 10 µL was injected into OrbiTrap Velos. |
Combined analysis:
Analysis ID | AN000741 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Waters Acquity |
Column | Waters Acquity CSH C18 (100 x 2.1mm,1.7um) |
MS Type | ESI |
MS instrument type | Orbitrap |
MS instrument name | Orbitrap |
Ion Mode | POSITIVE |
Units | MS |
Chromatography:
Chromatography ID: | CH000533 |
Instrument Name: | Waters Acquity |
Column Name: | Waters Acquity CSH C18 (100 x 2.1mm,1.7um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS000658 |
Analysis ID: | AN000741 |
Instrument Name: | Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
Ion Mode: | POSITIVE |